<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AExclusivity</id>
	<title>Definition:Exclusivity - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AExclusivity"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Exclusivity&amp;action=history"/>
	<updated>2026-04-30T13:43:13Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Exclusivity&amp;diff=17947&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Exclusivity&amp;diff=17947&amp;oldid=prev"/>
		<updated>2026-03-15T16:29:51Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;⏳ &amp;#039;&amp;#039;&amp;#039;Exclusivity&amp;#039;&amp;#039;&amp;#039; in the insurance transaction context refers to a negotiated period during which a seller agrees not to solicit, entertain, or negotiate with any other potential buyer, granting a single bidder the undivided right to conduct [[Definition:Due diligence | due diligence]] and negotiate definitive agreements for the acquisition of an insurance business. Exclusivity provisions are a standard feature of [[Definition:Merger and acquisition (M&amp;amp;A) | M&amp;amp;A]] processes involving [[Definition:Insurance carrier | insurance carriers]], [[Definition:Managing general agent (MGA) | MGAs]], [[Definition:Insurance broker | brokerages]], and [[Definition:Insurtech | insurtech]] companies, and they carry particular importance in insurance deals because the due diligence required — actuarial review of [[Definition:Loss reserve | reserves]], analysis of [[Definition:Reinsurance | reinsurance]] programs, regulatory pre-clearance, and examination of in-force [[Definition:Insurance policy | policy]] portfolios — is time-intensive and costly.&lt;br /&gt;
&lt;br /&gt;
🔄 Exclusivity is typically formalized in a letter or clause within a [[Definition:Letter of intent (LOI) | letter of intent]], specifying the duration (commonly four to eight weeks, though complex insurance transactions may require longer), the scope of restrictions on the seller, and any conditions for extension or early termination. The buyer uses the exclusivity window to deepen its actuarial and financial analysis, engage with insurance regulators informally about [[Definition:Regulatory approval | change-of-control]] requirements, finalize [[Definition:Debt commitment letter | financing arrangements]], and negotiate the purchase agreement. For the seller, granting exclusivity is a calculated trade-off: it removes competitive tension but accelerates the path to a binding deal. Sellers often condition exclusivity on the buyer meeting specific milestones — such as submitting a draft purchase agreement or completing key actuarial workstreams — to ensure the period is used productively rather than as a holding tactic.&lt;br /&gt;
&lt;br /&gt;
🛡️ The decision of when to grant exclusivity — and to whom — can shape the outcome of an entire insurance [[Definition:Merger and acquisition (M&amp;amp;A) | M&amp;amp;A]] process. In a structured auction, the seller&amp;#039;s advisers typically resist exclusivity until a preferred bidder emerges with a compelling offer and demonstrable [[Definition:Deal certainty | deal certainty]], including evidence of [[Definition:Regulatory approval | regulatory]] feasibility and financing capacity. Granting exclusivity too early can leave value on the table; granting it too late can cause the leading bidder to disengage. In insurance-specific situations — such as the sale of a [[Definition:Run-off | run-off]] book or a [[Definition:Lloyd&amp;#039;s syndicate | Lloyd&amp;#039;s syndicate]] where the annual capacity-setting cycle imposes hard deadlines — timing exclusivity correctly is essential to closing the transaction within the relevant market window. A well-managed exclusivity period signals to both parties that the transaction has moved from exploratory to committed, catalyzing the final push toward definitive documentation and signing.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Letter of intent (LOI)]]&lt;br /&gt;
* [[Definition:Deal certainty]]&lt;br /&gt;
* [[Definition:Due diligence]]&lt;br /&gt;
* [[Definition:Merger and acquisition (M&amp;amp;A)]]&lt;br /&gt;
* [[Definition:Non-disclosure agreement (NDA)]]&lt;br /&gt;
* [[Definition:Break fee]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>